首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.
【24h】

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.

机译:肌肉注射正常肌原细胞后,Duchenne肌营养不良患者肌纤维中的肌营养不良蛋白表达。

获取原文
获取原文并翻译 | 示例
       

摘要

Three Duchenne muscular dystrophy (DMD) patients received injections of myogenic cells obtained from skeletal muscle biopsies of normal donors. The cells (30 x 10 (6)) were injected in 1 cm3 of the tibialis anterior by 25 parallel injections. We performed similar patterns of saline injections in the contralateral muscles as controls. The patients received tacrolimus for immunosuppression. Muscle biopsies were performed at the injected sites 4 weeks later. We observed dystrophin-positive myofibers in the cell-grafted sites amounting to 9 (patient 1), 6.8 (patient 2), and 11% (patient 3). Since patients 1 and 2 had identified dystrophin-gene deletions these results were obtained using monoclonal antibodies specific to epitopes coded by the deleted exons. Donor dystrophin was absent in the control sites. Patient 3 had exon duplication and thus specific donor-dystrophin detection was not possible. However, there were fourfold more dystrophin-positive myofibers in the cell-grafted than in the control site. Donor-dystrophin transcripts were detected by RT-PCR (using primers reacting with a sequence int eh deleted exons) only in the cell-grafted sites in patients 1 and 2. Dystrophin transcripts were more abundant in the cell-grafted than in the control site in patient 3. Therefore, significant dystrophin expression can be obtained in teh skeletal muscles of DMD patients following specific conditions of cell delivery and immunosuppression.
机译:三名Duchenne肌营养不良症(DMD)患者接受了从正常供体骨骼肌活检中获得的成肌细胞注射。通过25次平行注射将细胞(30 x 10(6))注射到1 cm3的胫骨前骨中。我们在对侧肌肉中进行了与对照组一样的生理盐水注射模式。患者接受他克莫司进行免疫抑制。 4周后在注射部位进行肌肉活检。我们在细胞移植部位观察到肌营养不良蛋白阳性的肌纤维,分别为9(患者1),6.8(患者2)和11%(患者3)。由于患者1和2已鉴定出肌营养不良蛋白基因缺失,因此使用对缺失的外显子编码的表位具有特异性的单克隆抗体可获得这些结果。对照部位不存在供体肌营养不良蛋白。患者3具有外显子重复,因此无法进行特异性供体肌营养不良蛋白检测。但是,移植的细胞中肌营养不良蛋白阳性的肌纤维比对照部位多四倍。仅在患者1和2的细胞移植位点中,通过RT-PCR(使用与缺失的外显子序列反应的引物)检测供体肌营养不良蛋白转录物。在细胞移植物中,肌营养不良蛋白转录物比对照位点更为丰富。因此,在特定的细胞递送和免疫抑制条件下,DMD患者的骨骼肌中可以获得明显的肌营养不良蛋白表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号